-
1
-
-
33644759722
-
Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency
-
DOI 10.1111/j.1572-0241.2006.00492.x
-
Bork K, Staubach P, Eckardt AJ, Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to Cl inhibitor deficiency. Am J Gastroenterol 2006 101 : 619 627. (Pubitemid 43340941)
-
(2006)
American Journal of Gastroenterology
, vol.101
, Issue.3
, pp. 619-627
-
-
Bork, K.1
Staubach, P.2
Eckardt, A.J.3
Hardt, J.4
-
2
-
-
60949104520
-
Cl-inhibitor deficiency and angioedema: Molecular mechanisms and clinical progress
-
Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M. Cl-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med 2009 15 : 69 78.
-
(2009)
Trends Mol Med
, vol.15
, pp. 69-78
-
-
Cugno, M.1
Zanichelli, A.2
Foieni, F.3
Caccia, S.4
Cicardi, M.5
-
3
-
-
34249801766
-
Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant)
-
DOI 10.1016/j.jaci.2007.02.012, PII S009167490700379X
-
Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol 2007 119 : 1497 1503. (Pubitemid 46855846)
-
(2007)
Journal of Allergy and Clinical Immunology
, vol.119
, Issue.6
, pp. 1497-1503
-
-
Bork, K.1
Frank, J.2
Grundt, B.3
Schlattmann, P.4
Nussberger, J.5
Kreuz, W.6
-
4
-
-
0032490360
-
Plasma bradykinin in angiooedema
-
Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angiooedema. Lancet 1998 351 : 1693 1697.
-
(1998)
Lancet
, vol.351
, pp. 1693-1697
-
-
Nussberger, J.1
Cugno, M.2
Amstutz, C.3
Cicardi, M.4
Pellacani, A.5
Agostoni, A.6
-
5
-
-
0028364334
-
Hereditary angioneurotic oedema: Characterization of plasma kinin and vascular permeability-enhancing activities
-
Shoemaker LR, Schurman SJ, Donaldson VH, Davis AE, 3rd. Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities. Clin Exp Immunol 1994 95 : 22 8.
-
(1994)
Clin Exp Immunol
, vol.95
, pp. 22-8
-
-
Shoemaker, L.R.1
Schurman, S.J.2
Donaldson, V.H.3
Davis III, A.E.4
-
6
-
-
0036122075
-
Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor
-
DOI 10.1172/JCI200214211
-
Han ED, MacFarlane RC, Mulligan AN, Scafidi J, Davis AE, 3rd. Increased vascular permeability in Cl inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest 2002 109 : 1057 1063. (Pubitemid 34408580)
-
(2002)
Journal of Clinical Investigation
, vol.109
, Issue.8
, pp. 1057-1063
-
-
Han, E.D.1
MacFarlane, R.C.2
Mulligan, A.N.3
Scafidi, J.4
Davis III, A.E.5
-
7
-
-
32844469701
-
Hereditary angioedema: New findings concerning symptoms, affected organs, and course
-
DOI 10.1016/j.amjmed.2005.09.064, PII S0002934305010818
-
Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006 119 : 267 274. (Pubitemid 43255068)
-
(2006)
American Journal of Medicine
, vol.119
, Issue.3
, pp. 267-274
-
-
Bork, K.1
Meng, G.2
Staubach, P.3
Hardt, J.4
-
8
-
-
77950508522
-
Icatibant - Behandlung akuter Schwellungsanfälle des hereditären Angioödems (HAE)
-
Magerl M, Keßler B, Maurer M, Musch A. Icatibant - Behandlung akuter Schwellungsanfälle des hereditären Angioödems (HAE). Arzneimitteltherapie 2009 26 : 109 113.
-
(2009)
Arzneimitteltherapie
, vol.26
, pp. 109-113
-
-
Magerl, M.1
Keßler, B.2
Maurer, M.3
Musch, A.4
-
9
-
-
38049076305
-
Hereditary angioedema: A current state-of-the-art review, VIII: Current status of emerging therapies
-
Bernstein JA. Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies. Ann Allergy Asthma Immunol 2008 100 : S41 6.
-
(2008)
Ann Allergy Asthma Immunol
, vol.100
, pp. 41-6
-
-
Bernstein, J.A.1
|